News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Glycotope and Max Delbruck Center Form Research Collaboration to Investigate the Fusion of Glycotargets and Car Technology
Monday, September 25, 2023Glycotope GmbH Glycotope and the Max Delbrck Center for Molecular Medicine in the Helmholtz Association have forged a collaborative agreement to investigate the potential synergy between Glycotopes antibodies targeting proteincarbohydrate combined gl...
Jazz Pharmaceuticals Granted European Commission Authorization for Enrylaze® in Treating Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma
Friday, September 22, 2023Jazz Pharmaceuticals plc Nasdaq JAZZ has recently obtained marketing authorization from the European Commission EC for Enrylaze JZP a recombinant Erwinia asparaginase or crisantaspase
Gilgamesh Pharmaceuticals Achieves Success in Phase 1 SAD/MAD Clinical Trials for GM-1020
Friday, September 22, 2023Gilgamesh Pharma is delighted to announce the successful completion of its Phase Single Ascending Dose SAD and Multiple Ascending Dose MAD trials for GM a novel oral smallmolecule NMDA receptor channel blocker currently undergoing clinical developme...
Revolo Biotherapeutics Completes Phase 1 Multiple Ascending Dose Clinical Trial of '1104
Friday, September 22, 2023Revolo Biotherapeutics a company dedicated to developing therapies aimed at resetting the immune system for achieving longterm remission in patients with autoimmune and allergic diseases
SpyBiotech Submits Clinical Trial Application to MHRA for SPYVLP01
Thursday, September 21, 2023SpyBiotech a biotechnology company known for its groundbreaking vaccine platform technology effective against infectious diseases cancer and chronic conditions has announced the submission of a Clinical Trial Application CTA to the UKs Medicines and...
Orionis Biosciences and Genentech Collaborate to Explore Molecular Glue Class Medicines
Thursday, September 21, 2023Orionis Biosciences a privatelyowned company specializing in life sciences with an integrated drug discovery and chemical biology platform has announced a multiyear collaboration with Genentech a member of the Roche Group
Otsuka and Astex Secure European Commission Approval for INAQOVI® in the Treatment of Newly Diagnosed Acute Myeloid Leukemia in Adults
Wednesday, September 20, 2023Otsuka Pharmaceutical Europe Ltd Otsuka and Astex Pharmaceuticals Inc Astex have jointly announced that the European Commission EC has granted approval for INAQOVI as a monotherapy for the treatment of adult patients with newly diagnosed acute myeloi...
The Initial Dosing of IMPT-314 Commences in Phase 1/2 Study Investigating a Bispecific CD19/CD20 CAR T-cell Therapy for the Management of Aggressive B-cell Lymphoma
Wednesday, September 20, 2023ImmPACT Bio USA Inc ImmPACT Bio has initiated a Phase clinical trial for IMPT a novel bispecific CDCD CAR Tcell therapy designed to treat relapsed or refractory RR aggressive Bcell lymphoma The company recently announced the dosing of the first pati...
ALSA Ventures Launches Innovative Gene Therapy Company, Axovia Therapeutics, Focused on Ciliopathies Treatment
Wednesday, September 20, 2023ALSA Ventures a UKbased venture capital fund specializing in therapeutics has made significant announcements regarding its recent acquisition of Axovia Therapeutics Inc Alongside this acquisition ALSA Ventures has initiated the launch of a new portfo...
POINT Biopharma and Athebio Unveil Collaboration for the Development of Radioligands Targeting Designed Ankyrin Repeat Proteins
Tuesday, September 19, 2023POINT Biopharma Global Inc NASDAQ PNT a company focused on advancing radiopharmaceuticals with the potential to transform lives has announced a partnership and licensing agreement with Athebio AG Athebio
